Suppr超能文献

黏液性水肿昏迷导致急性冠状动脉综合征:一例报告

Myxedema Coma Leading to Acute Coronary Syndrome: A Case Report.

作者信息

Joshi Amir, Fernandes Warren, Yamparala Aishwarya, Patel Adit M, Jha Saroj K, Sharma Nitish, Wholey Richard

机构信息

Internal Medicine, Saint Vincent Hospital, UMass Chan Medical School, Worcester, USA.

Internal Medicine, Tribhuvan University Teaching Hospital, Kathmandu, NPL.

出版信息

Cureus. 2025 May 18;17(5):e84324. doi: 10.7759/cureus.84324. eCollection 2025 May.

Abstract

Myxedema coma is a rare and life-threatening medical condition. We present a case of poorly controlled hypothyroidism that initially caused myxedema coma and then led to acute coronary syndrome (ACS). A 57-year-old woman with a history of Hashimoto's thyroiditis and coronary artery bypass grafting (CABG) came in with fatigue and worsening left-sided chest pain that occurred even at rest for the past 12 hours. She has not been taking her levothyroxine as prescribed and has not been seeing her endocrinologist for follow-up. When she arrived, her vitals showed that she had a heart rate of 53 beats per minute (sinus bradycardia), but otherwise, she was stable. The laboratory tests showed elevated levels of high sensitivity troponin T at 42 ng/L (normal value: <14 ng/L), a thyroid stimulating hormone level of 408 mIU/L (normal value: 0.5-2.5 mIU/L), a free thyroxine level of 0.4 (normal range: 0.8-1.8 ng/mL), and a decreased glomerular filtration rate of 71 mL/min/1.73 m (normal range: 90-120 mL/min/1.73 m). Although the electrocardiogram did not show ST-T wave changes, the thrombolysis in myocardial infarction (TIMI) risk score was five. Additionally, there was a new onset decrease in ejection fraction to 40% and mild hypokinesia of the left ventricle on the echocardiogram. She was started on a heparin drip in the emergency department and subsequently underwent cardiac catheterization with drug-eluting stent (DES) placement. Myxedema coma score was 40 suggestive of coma risk myxedema and eventually, she was admitted to the intensive care unit. Her condition was managed using intravenous levothyroxine, liothyronine, and hydrocortisone. After her symptoms subsided, she was discharged with a prescription for dual antiplatelet agents and levothyroxine. Due to its rarity and high mortality rate, it is crucial for physicians to maintain a high level of suspicion for myxedema coma and promptly initiate treatment. This is especially important when a patient with a history of hypothyroidism presents with cardiac issues such as ACS or bradycardia that do not entirely align with the clinical picture.

摘要

黏液性水肿昏迷是一种罕见且危及生命的医学病症。我们报告一例甲状腺功能减退控制不佳的病例,该病例最初引发了黏液性水肿昏迷,随后导致急性冠状动脉综合征(ACS)。一名有桥本甲状腺炎和冠状动脉旁路移植术(CABG)病史的57岁女性因疲劳和左侧胸痛加重前来就诊,胸痛在过去12小时内即使休息时也会发作。她未按医嘱服用左甲状腺素,也未去内分泌科复诊。她到达时,生命体征显示心率为每分钟53次(窦性心动过缓),但其他方面情况稳定。实验室检查显示高敏肌钙蛋白T水平升高至42 ng/L(正常值:<14 ng/L),促甲状腺激素水平为408 mIU/L(正常值:0.5 - 2.5 mIU/L),游离甲状腺素水平为0.4(正常范围:0.8 - 1.8 ng/mL),肾小球滤过率降低至71 mL/min/1.73 m²(正常范围:90 - 120 mL/min/1.73 m²)。尽管心电图未显示ST - T波改变,但心肌梗死溶栓(TIMI)风险评分为5分。此外,超声心动图显示射血分数新降至40%,左心室轻度运动减弱。她在急诊科开始接受肝素滴注,随后接受了药物洗脱支架(DES)置入的心脏导管检查。黏液性水肿昏迷评分为40分,提示存在昏迷风险的黏液性水肿,最终她被收入重症监护病房。她的病情通过静脉注射左甲状腺素、碘塞罗宁和氢化可的松进行治疗。症状缓解后,她出院时开具了双联抗血小板药物和左甲状腺素的处方。由于其罕见性和高死亡率,医生对黏液性水肿昏迷保持高度怀疑并及时开始治疗至关重要。当有甲状腺功能减退病史的患者出现如ACS或心动过缓等心脏问题且与临床表现不完全相符时,这一点尤为重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aba1/12174829/764af15621ab/cureus-0017-00000084324-i01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验